SoftMedx Healthcare Limited (HKG:0648)
Hong Kong · Delayed Price · Currency is HKD 0.1870
-0.0080 (-4.10%)
At close: Feb 13, 2026
SoftMedx Healthcare Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 59.71 | 54.64 | 51.34 | 33.77 | 1.7 | 9.62 | |
Revenue Growth (YoY) | -2.83% | 6.43% | 52.05% | 1887.34% | -82.33% | -76.05% |
Cost of Revenue | 40.62 | 36.24 | 30.22 | 20.03 | 0.91 | 4.39 |
Gross Profit | 19.09 | 18.4 | 21.13 | 13.74 | 0.79 | 5.23 |
Selling, General & Admin | 5.96 | 9.84 | 15.09 | 23.02 | 21.84 | 37.41 |
Operating Expenses | 5.96 | 9.84 | 15.09 | 23.02 | 21.84 | 37.41 |
Operating Income | 13.14 | 8.56 | 6.04 | -9.28 | -21.05 | -32.18 |
Interest Expense | -1.19 | -1.32 | -12.94 | -15.55 | -16.27 | -18.1 |
Interest & Investment Income | 0.19 | 0.19 | 0.36 | 0.04 | 0 | - |
Currency Exchange Gain (Loss) | 8.04 | 8.04 | 4.2 | 8.79 | - | - |
Other Non Operating Income (Expenses) | -6.36 | 1.07 | 2.36 | 0.22 | 7.39 | 1.82 |
EBT Excluding Unusual Items | 13.82 | 16.54 | 0.02 | -15.78 | -29.93 | -48.47 |
Impairment of Goodwill | - | - | - | - | - | -5.04 |
Gain (Loss) on Sale of Investments | -4.3 | -16.61 | 19.08 | -0.73 | -2.74 | - |
Gain (Loss) on Sale of Assets | - | - | -4.73 | - | 7.95 | 0.65 |
Asset Writedown | - | - | - | -0.35 | - | - |
Other Unusual Items | 328.03 | 328.03 | - | 0.22 | - | 0.39 |
Pretax Income | 337.55 | 327.95 | 14.37 | -16.63 | -24.72 | -52.47 |
Income Tax Expense | 1.78 | 1.64 | 1.86 | 2.59 | - | - |
Earnings From Continuing Operations | 335.76 | 326.32 | 12.51 | -19.23 | -24.72 | -52.47 |
Net Income to Company | 335.76 | 326.32 | 12.51 | -19.23 | -24.72 | -52.47 |
Minority Interest in Earnings | - | - | - | - | -1.56 | 1.62 |
Net Income | 335.76 | 326.32 | 12.51 | -19.23 | -26.28 | -50.85 |
Net Income to Common | 335.76 | 326.32 | 12.51 | -19.23 | -26.28 | -50.85 |
Net Income Growth | 3162.37% | 2508.24% | - | - | - | - |
Shares Outstanding (Basic) | 326 | 326 | 326 | 326 | 326 | 326 |
Shares Outstanding (Diluted) | 326 | 326 | 326 | 326 | 326 | 326 |
EPS (Basic) | 1.03 | 1.00 | 0.04 | -0.06 | -0.08 | -0.16 |
EPS (Diluted) | 1.03 | 1.00 | 0.04 | -0.06 | -0.08 | -0.16 |
EPS Growth | 3162.47% | 2508.30% | - | - | - | - |
Free Cash Flow | 17.07 | 3.88 | -4.49 | -3.38 | -7.14 | -9.87 |
Free Cash Flow Per Share | 0.05 | 0.01 | -0.01 | -0.01 | -0.02 | -0.03 |
Gross Margin | 31.97% | 33.67% | 41.15% | 40.68% | 46.50% | 54.33% |
Operating Margin | 22.00% | 15.67% | 11.76% | -27.50% | -1238.79% | -334.65% |
Profit Margin | 562.36% | 597.22% | 24.37% | -56.94% | -1546.50% | -528.71% |
Free Cash Flow Margin | 28.59% | 7.10% | -8.75% | -10.00% | -420.36% | -102.62% |
EBITDA | 13.28 | 8.73 | 6.26 | -8.95 | -20.83 | -31.73 |
EBITDA Margin | 22.24% | 15.98% | 12.20% | -26.51% | - | - |
D&A For EBITDA | 0.14 | 0.17 | 0.23 | 0.33 | 0.21 | 0.45 |
EBIT | 13.14 | 8.56 | 6.04 | -9.28 | -21.05 | -32.18 |
EBIT Margin | 22.00% | 15.67% | 11.76% | -27.50% | - | - |
Effective Tax Rate | 0.53% | 0.50% | 12.93% | - | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.